CureVac NV
Biotechnology
Healthcare
CVAC
225 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.35
52 week high
5.60
high
5.39
52 week low
0.00
previous Close
5.36
P/E ratio
market cap
1.23 B
div yield
0
net incoming
-59.56 M
-81.80 %
net profit margin
-4783.94 %
-4557.00 %
operating incoming
-61.75 M
-41.10 %
net change in cash
-44.93 M
35.00 %
cash on hand
393 M
-18.48 %
cost of revenue
2.21 M
48.92 %
top